chr7-156675698-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030936.4(RNF32):āc.687C>Gā(p.Phe229Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,529,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030936.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF32 | NM_030936.4 | c.687C>G | p.Phe229Leu | missense_variant, splice_region_variant | 8/9 | ENST00000317955.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF32 | ENST00000317955.10 | c.687C>G | p.Phe229Leu | missense_variant, splice_region_variant | 8/9 | 1 | NM_030936.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000856 AC: 13AN: 151922Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251282Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135792
GnomAD4 exome AF: 0.000118 AC: 163AN: 1377762Hom.: 0 Cov.: 35 AF XY: 0.000118 AC XY: 81AN XY: 687888
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151922Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74194
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 28, 2022 | The c.687C>G (p.F229L) alteration is located in exon 8 (coding exon 7) of the RNF32 gene. This alteration results from a C to G substitution at nucleotide position 687, causing the phenylalanine (F) at amino acid position 229 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at